This proof-of-concept study with short-term follow-up reports the development of a mouse hepatic artery embolization (HAE) model for translational research of interventional oncology. To induce liver metastases, luciferase-expressing colon cancer cells were injected into the spleens of BALB/c mice. After confirming hepatic tumor engraftment, HAE was performed by retrograde puncture of the lienogastric artery using a 34G needle under microscopy. Six mice received microbead injections (HAE group), and five served as controls. Technical success rate was 100%; however, 2-day survival was 67% (4/6) for the HAE group. Bioluminescent imaging the day after the procedure showed a significant reduction in luciferase activity for the HAE group (p < 0.001), but not for controls (p = 0.367). Histological analysis revealed larger necrotic areas in the HAE group than in controls (IQR, 18.2% vs. 0.0%; p < 0.05). This model might provide a valuable platform for translational research of interventional oncology.
{"title":"Development of Preclinical Mouse Hepatic Artery Embolization Model for Translational Research in Interventional Radiology.","authors":"Reona Wada, Haruyuki Takaki, Hiroshi Kodama, Yutaka Hirata, Naoki Yokota, Eisuke Ueshima, Takashi Shinkai, Kosuke Matsuda, Sayuri Nishimoto, Ako Nakase, Koichiro Yamakado","doi":"10.1016/j.jvir.2026.108574","DOIUrl":"https://doi.org/10.1016/j.jvir.2026.108574","url":null,"abstract":"<p><p>This proof-of-concept study with short-term follow-up reports the development of a mouse hepatic artery embolization (HAE) model for translational research of interventional oncology. To induce liver metastases, luciferase-expressing colon cancer cells were injected into the spleens of BALB/c mice. After confirming hepatic tumor engraftment, HAE was performed by retrograde puncture of the lienogastric artery using a 34G needle under microscopy. Six mice received microbead injections (HAE group), and five served as controls. Technical success rate was 100%; however, 2-day survival was 67% (4/6) for the HAE group. Bioluminescent imaging the day after the procedure showed a significant reduction in luciferase activity for the HAE group (p < 0.001), but not for controls (p = 0.367). Histological analysis revealed larger necrotic areas in the HAE group than in controls (IQR, 18.2% vs. 0.0%; p < 0.05). This model might provide a valuable platform for translational research of interventional oncology.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"108574"},"PeriodicalIF":2.6,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-02DOI: 10.1016/j.jvir.2026.108573
Hyo-Cheol Kim, Myungsu Lee, Do Hoon Kim, Jin Woo Choi, Jayoun Kim, Minseok Suh, Jin Chul Paeng
Purpose: To identify the optimal tumor absorbed dose (TAD) thresholds predictive of radiological complete response (CR) in patients with localized hepatocellular carcinoma (HCC) undergoing resin-based Y-90 transarterial radioembolization (TARE).
Materials and methods: This retrospective single-center study included 160 HCC patients treated with resin-based Y-90 TARE, four dosimetric metrics-mean absorbed dose (mAD), pre-treatment TAD (Pre-TAD), post-treatment TAD (Post-TAD), and virtual TAD (vTAD)-were analyzed. Pre-TAD and Post-TAD were retrospectively measured using SPECT/CT and PET/CT images, respectively. The vTAD was calculated assuming that Y-90 microspheres were distributed exclusively within the tumor. Tumor response was assessed using modified RECIST criteria. Cut-off thresholds for predicting CR were determined using maximally selected rank statistics.
Results: Mean tumor size was 8.6cm (median size, 7.9 cm [IQR, 5.6-10.2 cm]), and 68 (42.5%) patients had single nodular tumor. Median mAD, Pre-TAD, Post-TAD, and vTAD were 178Gy (IQR, 124 - 228 Gy), 375 Gy (IQR, 219 - 514 Gy), 427 Gy (IQR, 283 - 605 Gy), and 728 Gy (IQR, 417 - 1105 Gy), respectively. Complete response was achieved in 37.5% (60/160) of patients. Multivariate analysis identified vTAD > 597 Gy as the independent predictor of CR (p = 0.004).
Conclusion: A vTAD ≥ 600 Gy represents a practical and reliable threshold for predicting CR in resin-based TARE. Given its ease of calculation and independence from registration artifacts, vTAD may serve as a valuable dosimetric tool in both clinical practice and treatment planning.
{"title":"High-Dose Radioembolization with Resin Microspheres Limited by Lung Shunt for Localized Hepatocellular Carcinoma: Virtual Tumor Absorbed Dose as a Predictor of Complete Response.","authors":"Hyo-Cheol Kim, Myungsu Lee, Do Hoon Kim, Jin Woo Choi, Jayoun Kim, Minseok Suh, Jin Chul Paeng","doi":"10.1016/j.jvir.2026.108573","DOIUrl":"https://doi.org/10.1016/j.jvir.2026.108573","url":null,"abstract":"<p><strong>Purpose: </strong>To identify the optimal tumor absorbed dose (TAD) thresholds predictive of radiological complete response (CR) in patients with localized hepatocellular carcinoma (HCC) undergoing resin-based Y-90 transarterial radioembolization (TARE).</p><p><strong>Materials and methods: </strong>This retrospective single-center study included 160 HCC patients treated with resin-based Y-90 TARE, four dosimetric metrics-mean absorbed dose (mAD), pre-treatment TAD (Pre-TAD), post-treatment TAD (Post-TAD), and virtual TAD (vTAD)-were analyzed. Pre-TAD and Post-TAD were retrospectively measured using SPECT/CT and PET/CT images, respectively. The vTAD was calculated assuming that Y-90 microspheres were distributed exclusively within the tumor. Tumor response was assessed using modified RECIST criteria. Cut-off thresholds for predicting CR were determined using maximally selected rank statistics.</p><p><strong>Results: </strong>Mean tumor size was 8.6cm (median size, 7.9 cm [IQR, 5.6-10.2 cm]), and 68 (42.5%) patients had single nodular tumor. Median mAD, Pre-TAD, Post-TAD, and vTAD were 178Gy (IQR, 124 - 228 Gy), 375 Gy (IQR, 219 - 514 Gy), 427 Gy (IQR, 283 - 605 Gy), and 728 Gy (IQR, 417 - 1105 Gy), respectively. Complete response was achieved in 37.5% (60/160) of patients. Multivariate analysis identified vTAD > 597 Gy as the independent predictor of CR (p = 0.004).</p><p><strong>Conclusion: </strong>A vTAD ≥ 600 Gy represents a practical and reliable threshold for predicting CR in resin-based TARE. Given its ease of calculation and independence from registration artifacts, vTAD may serve as a valuable dosimetric tool in both clinical practice and treatment planning.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"108573"},"PeriodicalIF":2.6,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146119622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To compare the efficacy of preemptive oxycodone versus sufentanil for acute and delayed pain control after transcatheter arterial chemoembolization (TACE).
Materials and methods: In this prospective, double-blind trial, 40 patients scheduled for TACE were randomized to receive intravenous oxycodone (0.1 mg/kg) or sufentanil (0.1 μg/kg) 15 minutes pre-TACE. Pain intensity was assessed using a visual analogue scale (VAS) during acute (0-24h) and delayed (days 2-7) phases. Inflammatory biomarkers (white blood cell count, neutrophil percentage, C-reactive protein, interleukin-6 [IL-6]) were measured at baseline and 24 hours post-TACE. The primary outcome was the highest acute-phase VAS scores; secondary outcomes included delayed-phase pain, changes in inflammatory biomarkers, and adverse events.
Results: Oxycodone demonstrated superior analgesia, with lower (median, interquartile range[IQR]) intraprocedural VAS scores (0[0-1.0] vs 3.5[1.3-4.8], P<0.001) and reduced incidence of moderate-to-severe pain (5% vs 50%, P=0.003). This benefit persisted at 1-6 hours post-TACE (0[0-1.0] vs 2[0-3.0], P=0.042). During the delayed phase, oxycodone maintained lower pain scores (0[0-0] vs 0[0-3.8], P=0.042) and fewer episodes of moderate pain (0% vs 25%, P=0.047). IL-6 elevation was greater in patients developing delayed pain (671.16% vs 135.97% increase, P=0.030). Adverse event rates were comparable.
Conclusion: Preemptive oxycodone provided more effective acute and delayed pain control after TACE compared to sufentanil, with comparable safety. The association between IL-6 elevation and delayed pain suggests an inflammatory pain component, supporting further investigation of combined opioid and anti-inflammatory strategies.
{"title":"Preemptive Oxycodone Versus Sufentanil for Acute and Delayed Pain After Transcatheter Arterial Chemoembolization: A Randomized Controlled Trial with Inflammatory Biomarker Analysis.","authors":"Wen-Tao Wu, Bo-Jing Xu, Bing Li, Yu Hang, Qing-Quan Zu, Wei-Zhong Zhou, Sheng Liu, Hai-Bin Shi, Yu Chen","doi":"10.1016/j.jvir.2026.108570","DOIUrl":"https://doi.org/10.1016/j.jvir.2026.108570","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the efficacy of preemptive oxycodone versus sufentanil for acute and delayed pain control after transcatheter arterial chemoembolization (TACE).</p><p><strong>Materials and methods: </strong>In this prospective, double-blind trial, 40 patients scheduled for TACE were randomized to receive intravenous oxycodone (0.1 mg/kg) or sufentanil (0.1 μg/kg) 15 minutes pre-TACE. Pain intensity was assessed using a visual analogue scale (VAS) during acute (0-24h) and delayed (days 2-7) phases. Inflammatory biomarkers (white blood cell count, neutrophil percentage, C-reactive protein, interleukin-6 [IL-6]) were measured at baseline and 24 hours post-TACE. The primary outcome was the highest acute-phase VAS scores; secondary outcomes included delayed-phase pain, changes in inflammatory biomarkers, and adverse events.</p><p><strong>Results: </strong>Oxycodone demonstrated superior analgesia, with lower (median, interquartile range[IQR]) intraprocedural VAS scores (0[0-1.0] vs 3.5[1.3-4.8], P<0.001) and reduced incidence of moderate-to-severe pain (5% vs 50%, P=0.003). This benefit persisted at 1-6 hours post-TACE (0[0-1.0] vs 2[0-3.0], P=0.042). During the delayed phase, oxycodone maintained lower pain scores (0[0-0] vs 0[0-3.8], P=0.042) and fewer episodes of moderate pain (0% vs 25%, P=0.047). IL-6 elevation was greater in patients developing delayed pain (671.16% vs 135.97% increase, P=0.030). Adverse event rates were comparable.</p><p><strong>Conclusion: </strong>Preemptive oxycodone provided more effective acute and delayed pain control after TACE compared to sufentanil, with comparable safety. The association between IL-6 elevation and delayed pain suggests an inflammatory pain component, supporting further investigation of combined opioid and anti-inflammatory strategies.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"108570"},"PeriodicalIF":2.6,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146101021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-30DOI: 10.1016/j.jvir.2026.108571
Anne van den Brekel, Kirsten de Vries, Veerle A Lantinga, Tess J Snoeijink, Arja Gerritsen, Milou Boswinkel, Joey Roosen, Alexandra G Arranja, Marius C van den Heuvel, Cyril Moers, Jurgen J Fütterer, Koert P de Jong, Vincent E de Meijer, Simeon J S Ruiter, J Frank W Nijsen
Purpose: To investigate dose heterogeneity in liver tumors and non-tumor target liver following transarterial radioembolization (TARE) by developing an experimental magnetic resonance imaging (MRI)-compatible ex vivo perfusion model based on human tumor-bearing livers, and to validate the observed heterogeneity patterns against in vivo data.
Materials and methods: Fractionated TARE was performed under MRI in four machine-perfused human tumor-bearing liver explants using fluorescent holmium microspheres. Dose heterogeneity was quantified by calculating the homogeneity index (HI) from MRI-based dose maps (voxel size <2.5 mm). These results were validated against HI values from two TARE-treated patients. Fluorescence microscopy was used to assess the microscopic distribution of four distinct microsphere fractions.
Results: MRI-based dose maps revealed lower heterogeneity in liver tumors (mean HI 2.41, range 0.72-4.43) compared to non-tumor target liver (mean HI 2.95, range 1.58-5.94), but this difference was not significant (p = 0.06) and was primarily driven by higher microsphere concentrations in tumors, which were associated with reduced heterogeneity (ρ = -0.88, p < 0.001). Microspheres administered in consecutive fractions decreased the HI while mostly preserving the spatial distribution pattern of earlier fractions, as confirmed by fluorescence microscopy.
Conclusion: TARE induces heterogeneous dose distributions in both liver tumors and non-tumor target liver at a scale below the resolution of nuclear imaging. While these findings provide insight into microsphere distribution and dose heterogeneity, the clinical significance of fine-scale dose heterogeneity and its potential impact on treatment outcomes remains uncertain and warrants further investigation.
目的:通过建立基于人荷瘤肝脏的磁共振成像(MRI)兼容的实验性离体灌注模型,研究经动脉放射栓塞(TARE)后肝脏肿瘤和非肿瘤靶肝脏的剂量异质性,并通过体内数据验证所观察到的异质性模式。材料与方法:采用荧光钬微球对4例机器灌注的人荷瘤肝移植体在MRI下进行TARE分级。结果:与非肿瘤靶肝(平均HI 2.95,范围1.58-5.94)相比,基于mri的剂量图显示肝脏肿瘤的异质性较低(平均HI 2.41,范围0.72-4.43),但这种差异不显著(p = 0.06),主要是由于肿瘤中较高的微球浓度与异质性降低相关(ρ = -0.88, p < 0.001)。荧光显微镜证实,连续给药的微球降低了HI,但大部分保留了早期部分的空间分布模式。结论:TARE在肝脏肿瘤和非肿瘤靶肝中均诱导了不均匀的剂量分布,其尺度低于核成像分辨率。虽然这些发现提供了对微球分布和剂量异质性的见解,但细尺度剂量异质性的临床意义及其对治疗结果的潜在影响仍不确定,需要进一步研究。
{"title":"Dose heterogeneity in transarterial radioembolization after fractional administration of holmium microspheres: a study in perfused human tumor-bearing liver explants under MRI.","authors":"Anne van den Brekel, Kirsten de Vries, Veerle A Lantinga, Tess J Snoeijink, Arja Gerritsen, Milou Boswinkel, Joey Roosen, Alexandra G Arranja, Marius C van den Heuvel, Cyril Moers, Jurgen J Fütterer, Koert P de Jong, Vincent E de Meijer, Simeon J S Ruiter, J Frank W Nijsen","doi":"10.1016/j.jvir.2026.108571","DOIUrl":"https://doi.org/10.1016/j.jvir.2026.108571","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate dose heterogeneity in liver tumors and non-tumor target liver following transarterial radioembolization (TARE) by developing an experimental magnetic resonance imaging (MRI)-compatible ex vivo perfusion model based on human tumor-bearing livers, and to validate the observed heterogeneity patterns against in vivo data.</p><p><strong>Materials and methods: </strong>Fractionated TARE was performed under MRI in four machine-perfused human tumor-bearing liver explants using fluorescent holmium microspheres. Dose heterogeneity was quantified by calculating the homogeneity index (HI) from MRI-based dose maps (voxel size <2.5 mm). These results were validated against HI values from two TARE-treated patients. Fluorescence microscopy was used to assess the microscopic distribution of four distinct microsphere fractions.</p><p><strong>Results: </strong>MRI-based dose maps revealed lower heterogeneity in liver tumors (mean HI 2.41, range 0.72-4.43) compared to non-tumor target liver (mean HI 2.95, range 1.58-5.94), but this difference was not significant (p = 0.06) and was primarily driven by higher microsphere concentrations in tumors, which were associated with reduced heterogeneity (ρ = -0.88, p < 0.001). Microspheres administered in consecutive fractions decreased the HI while mostly preserving the spatial distribution pattern of earlier fractions, as confirmed by fluorescence microscopy.</p><p><strong>Conclusion: </strong>TARE induces heterogeneous dose distributions in both liver tumors and non-tumor target liver at a scale below the resolution of nuclear imaging. While these findings provide insight into microsphere distribution and dose heterogeneity, the clinical significance of fine-scale dose heterogeneity and its potential impact on treatment outcomes remains uncertain and warrants further investigation.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"108571"},"PeriodicalIF":2.6,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146101054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-29DOI: 10.1016/j.jvir.2026.108562
Taylor Hoffman, Rozan Bokhari, Isabelle Echelman, Ruben Geevarghese, Eric Lis, Stephen B Solomon, Francois H Cornelis
Purpose: To evaluate the safety and effectiveness of coil-only middle meningeal artery embolization (MMAE) for the treatment of subacute to chronic subdural hematoma (SDH) in patients with cancer.
Materials and methods: A single-center retrospective analysis was performed of 30 patients with cancer with SDH, 12 of whom had bilateral hematomas, who underwent MMAE of the affected side(s) using coils alone between 2022 and 2025. Clinical and radiographic outcomes were evaluated, including hematoma resolution, change in SDH thickness, need for reoperation, and overall survival.
Results: Median SDH thickness declined from 12 mm (interquartile range [IQR], 9 mm) before embolization to 3.6 mm (IQR, 8.8 mm) on final imaging (Wilcoxon signed-rank z = 4.59, P < .001). A ≥50% reduction was observed in 56% of SDHs, and complete radiographic resolution was observed in 37%. One patient (3%) required surgical evacuation after MMAE. Seventeen patients (59%) died due to cancer progression during follow-up. Median survival was significantly longer among patients with reduced hematoma thickness at initial follow-up imaging (148 vs 29 days, log-rank P = .0002).
Conclusions: Coil-only MMAE may be a safe and effective treatment option for SDH in patients with cancer. Reduction in hematoma thickness was associated with longer survival in this high-risk population.
目的:评价单线圈脑膜中动脉(MMA)栓塞治疗亚急性至慢性肿瘤患者硬膜下血肿(SDH)的安全性和有效性。材料和方法:对30例SDH癌症患者进行单中心回顾性分析,其中12例患有双侧血肿,这些患者在2022年至2025年间仅使用线圈对患侧进行MMA栓塞。评估临床和影像学结果,包括血肿消退、SDH厚度变化、再次手术需求和总生存期。结果:中位SDH厚度从栓塞前的12 mm (IQR 9)下降到最终成像时的3.6 mm (IQR 8.8) (Wilcoxon sign -rank z = 4.59, p < 0.001)。在56%的sdh中观察到≥50%的减少,在37%的sdh中观察到完全的放射学分辨率。1例(3%)患者在MMAE后需要手术撤离。17例(59%)患者在随访期间因癌症进展死亡。在初始随访成像时血肿厚度减少的患者中位生存期明显更长(148天vs 29天,log-rank p = 0.0002)。结论:单线圈MMAE可能是一种安全有效的治疗癌症患者SDH的方法。在这一高危人群中,血肿厚度的减少与更长的生存期相关。
{"title":"Middle Meningeal Artery Embolization Using Coils for Subdural Hematoma in Patients with Cancer: Safety and Effectiveness.","authors":"Taylor Hoffman, Rozan Bokhari, Isabelle Echelman, Ruben Geevarghese, Eric Lis, Stephen B Solomon, Francois H Cornelis","doi":"10.1016/j.jvir.2026.108562","DOIUrl":"10.1016/j.jvir.2026.108562","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the safety and effectiveness of coil-only middle meningeal artery embolization (MMAE) for the treatment of subacute to chronic subdural hematoma (SDH) in patients with cancer.</p><p><strong>Materials and methods: </strong>A single-center retrospective analysis was performed of 30 patients with cancer with SDH, 12 of whom had bilateral hematomas, who underwent MMAE of the affected side(s) using coils alone between 2022 and 2025. Clinical and radiographic outcomes were evaluated, including hematoma resolution, change in SDH thickness, need for reoperation, and overall survival.</p><p><strong>Results: </strong>Median SDH thickness declined from 12 mm (interquartile range [IQR], 9 mm) before embolization to 3.6 mm (IQR, 8.8 mm) on final imaging (Wilcoxon signed-rank z = 4.59, P < .001). A ≥50% reduction was observed in 56% of SDHs, and complete radiographic resolution was observed in 37%. One patient (3%) required surgical evacuation after MMAE. Seventeen patients (59%) died due to cancer progression during follow-up. Median survival was significantly longer among patients with reduced hematoma thickness at initial follow-up imaging (148 vs 29 days, log-rank P = .0002).</p><p><strong>Conclusions: </strong>Coil-only MMAE may be a safe and effective treatment option for SDH in patients with cancer. Reduction in hematoma thickness was associated with longer survival in this high-risk population.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"108562"},"PeriodicalIF":2.6,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885235/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146094766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-29DOI: 10.1016/j.jvir.2026.108572
Mehmet Semih Çakır, Koray Güven
{"title":"Snare-Assisted Interanastomotic Catheterization for Bile Leak Secondary to Hepaticojejunostomy Dehiscence.","authors":"Mehmet Semih Çakır, Koray Güven","doi":"10.1016/j.jvir.2026.108572","DOIUrl":"https://doi.org/10.1016/j.jvir.2026.108572","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"108572"},"PeriodicalIF":2.6,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146097641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To evaluate differences in burnout, perceived stress, and job satisfaction among physicians, nurses, and technologists working in interventional radiology (IR) and interventional cardiology (IC) teams within a high-volume, 24/7 tertiary care center.
Materials and methods: This cross-sectional, questionnaire-based study was conducted at Turkey's largest high-volume tertiary interventional center. Data were collected on-site using standardized instruments: the Maslach Burnout Inventory, Perceived Stress Scale-14, and Minnesota Satisfaction Questionnaire. Group comparisons were performed using the Mann-Whitney U and chi-square tests. Structural equation modeling (SEM) was used to explore direct and indirect effects among stress, burnout, and job satisfaction.
Results: IR physicians reported significantly higher emotional exhaustion (median, 26.0 vs 20.0; P = .025) and depersonalization (17.0 vs 8.0, P < .001) than IC physicians. Among staff, burnout levels were greater in IC personnel than in IR staff, with higher scores in emotional exhaustion (20.5 vs 15.0, P = .002) and depersonalization (9.5 vs 5.0, P = .010). IC staff also demonstrated significant lower job satisfaction across all subscales (all P < .001). SEM revealed that perceived stress negatively impacted job satisfaction directly (β = -0.903, P < .001) and indirectly via emotional exhaustion. The model explained for 34.4% of the variance in job satisfaction.
Conclusions: Burnout, perceived stress, and job satisfaction levels differed between IR and IC teams. IR physicians reported higher levels of burnout, whereas IC staff demonstrated lower job satisfaction. These findings highlight the need for targeted institutional strategies tailored to the specific needs of each group.
{"title":"Burnout, Perceived Stress, and Job Satisfaction in Interventional Radiology and Cardiology: Insights from a High-Volume Tertiary Center in Turkey.","authors":"Çağrı Erdim, Neşe Kavruk Erdim, Ufuk Yıldız, Özgür Kılıçkesmez","doi":"10.1016/j.jvir.2026.108554","DOIUrl":"10.1016/j.jvir.2026.108554","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate differences in burnout, perceived stress, and job satisfaction among physicians, nurses, and technologists working in interventional radiology (IR) and interventional cardiology (IC) teams within a high-volume, 24/7 tertiary care center.</p><p><strong>Materials and methods: </strong>This cross-sectional, questionnaire-based study was conducted at Turkey's largest high-volume tertiary interventional center. Data were collected on-site using standardized instruments: the Maslach Burnout Inventory, Perceived Stress Scale-14, and Minnesota Satisfaction Questionnaire. Group comparisons were performed using the Mann-Whitney U and chi-square tests. Structural equation modeling (SEM) was used to explore direct and indirect effects among stress, burnout, and job satisfaction.</p><p><strong>Results: </strong>IR physicians reported significantly higher emotional exhaustion (median, 26.0 vs 20.0; P = .025) and depersonalization (17.0 vs 8.0, P < .001) than IC physicians. Among staff, burnout levels were greater in IC personnel than in IR staff, with higher scores in emotional exhaustion (20.5 vs 15.0, P = .002) and depersonalization (9.5 vs 5.0, P = .010). IC staff also demonstrated significant lower job satisfaction across all subscales (all P < .001). SEM revealed that perceived stress negatively impacted job satisfaction directly (β = -0.903, P < .001) and indirectly via emotional exhaustion. The model explained for 34.4% of the variance in job satisfaction.</p><p><strong>Conclusions: </strong>Burnout, perceived stress, and job satisfaction levels differed between IR and IC teams. IR physicians reported higher levels of burnout, whereas IC staff demonstrated lower job satisfaction. These findings highlight the need for targeted institutional strategies tailored to the specific needs of each group.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"108554"},"PeriodicalIF":2.6,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146087971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-27DOI: 10.1016/j.jvir.2026.108551
Ramazan Kutlu, Nurullah Dag, Eldiiar Saparbekov, Sezai Yilmaz
Objective: To evaluate the clinical application and outcomes of a percutaneously placed, retrievable, fully covered self-expandable metallic stent (FCSEMS) with retrieval string with an alternative retrieval string fixation technique for the management of benign biliary conditions.
Methods: This single-center, retrospective study included 87 patients who underwent percutaneous placement of retrievable FCSEMS with retrieval string between March 2020 and February 2025. Patients were categorized according to indication: anastomotic stricture (n = 30), bile leak (n = 41), and biliary stones (n = 16). The primary outcomes were technical and clinical success rates, with secondary outcomes including complication rates and long-term patency.
Results: Technical success was achieved in 98% of procedures. Clinical success rates were 97% for anastomotic strictures (6-month follow-up), 91% for bile leaks, and 94% for biliary stones. Mean stent indwelling times were 3.0 ± 0.8 months, 1.9 ± 0.7 months, and 0.7 ± 0.3 months, respectively. The estimated mean recurrence-free duration for anastomotic strictures was 41.7 months, with a 36-month patency rate of 67%. Stent migration occurred in 3.4% (3/87) of patients, while one retrieval string breakage and three cases of cholangitis were recorded.
Conclusion: In this single-center observational cohort, percutaneous implantation of a retrievable FCSEMS with retrieval string using an alternative fixation technique appears to be a safe and effective approach for the management of benign biliary conditions. In our cohort, this technique was associated with favorable long-term patency in anastomotic strictures, favorable outcomes in bile leaks and stones, and a low rate of stent migration.
{"title":"Benign Biliary Strictures, Leaks, and Stones: Clinical Application of Retrievable Fully Covered Self-Expandable Metallic Biliary Stent with an Alternative Retrieval String Fixation Method.","authors":"Ramazan Kutlu, Nurullah Dag, Eldiiar Saparbekov, Sezai Yilmaz","doi":"10.1016/j.jvir.2026.108551","DOIUrl":"https://doi.org/10.1016/j.jvir.2026.108551","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the clinical application and outcomes of a percutaneously placed, retrievable, fully covered self-expandable metallic stent (FCSEMS) with retrieval string with an alternative retrieval string fixation technique for the management of benign biliary conditions.</p><p><strong>Methods: </strong>This single-center, retrospective study included 87 patients who underwent percutaneous placement of retrievable FCSEMS with retrieval string between March 2020 and February 2025. Patients were categorized according to indication: anastomotic stricture (n = 30), bile leak (n = 41), and biliary stones (n = 16). The primary outcomes were technical and clinical success rates, with secondary outcomes including complication rates and long-term patency.</p><p><strong>Results: </strong>Technical success was achieved in 98% of procedures. Clinical success rates were 97% for anastomotic strictures (6-month follow-up), 91% for bile leaks, and 94% for biliary stones. Mean stent indwelling times were 3.0 ± 0.8 months, 1.9 ± 0.7 months, and 0.7 ± 0.3 months, respectively. The estimated mean recurrence-free duration for anastomotic strictures was 41.7 months, with a 36-month patency rate of 67%. Stent migration occurred in 3.4% (3/87) of patients, while one retrieval string breakage and three cases of cholangitis were recorded.</p><p><strong>Conclusion: </strong>In this single-center observational cohort, percutaneous implantation of a retrievable FCSEMS with retrieval string using an alternative fixation technique appears to be a safe and effective approach for the management of benign biliary conditions. In our cohort, this technique was associated with favorable long-term patency in anastomotic strictures, favorable outcomes in bile leaks and stones, and a low rate of stent migration.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"108551"},"PeriodicalIF":2.6,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146087956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
To assess the feasibility, safety, and effectiveness of superselective transarterial embolization (TAE) using imipenem/cilastatin sodium for plantar fasciitis (PF) refractory to conservative management.
Materials and Methods
This retrospective study included 12 patients (50% men; mean age, 36 years [SD ± 9.07]) with PF (pain on palpation along the proximal plantar fascia and thickened plantar fascia [>4 mm] on magnetic resonance [MR] imaging) refractory to conservative management for ≥3 months. Superselective cannulation of branches from the posterior tibial artery (PTA), supplying the point of maximal pain at the plantar fascia origin, was performed, and branches showing hypervascular staining (contrast blush) were embolized using a suspension of 500 mg of imipenem/cilastatin sodium in 5 mL of iodinated contrast agent. Visual analog scale (VAS) was used to assess pain at baseline, 1 day, 1 week, 1 month, 3 months, 6 months, 9 months, and 12 months after procedure.
Results
PTA branches supplying area of hypervascular staining could be superselectively embolized in 11 of 12 patients (technical success, 91.7%; mean number of arteries embolized, 1.5 [SD ± 0.7]; mean amount of embolizing agent used, 1.1 mL [SD ± 0.5]). A significant decrease in VAS score was noted on day 1 after procedure (2.27 [SD ±1.19] vs 7.36 [SD ± 0.92]; P < .0001), which persisted through 12 months of follow-up. Clinical success, defined as ≥50% reduction in VAS score at 6 months, was achieved in 8 of 11 (72.73%) patients who underwent embolization and was sustained through 12 months of follow-up.
Conclusions
Superselective TAE using imipenem/cilastatin sodium is feasible, safe, and effective in alleviating pain associated with PF refractory to conservative management, with a low risk of adverse events.
目的:评价亚胺培南西司他汀钠超选择性经动脉栓塞治疗难治性足底筋膜炎(PF)的可行性、安全性和有效性。材料和方法:本回顾性研究纳入12例PF患者(50%男性,平均年龄:36±9.07岁),PF(沿足底近端筋膜触诊疼痛,MRI显示足底筋膜增厚[bbb40mm]),保守治疗难治≥3个月。在足底筋膜起源处提供最大疼痛点的胫骨后动脉(PTA)的分支进行超选择性插管,并使用500mg亚胺培南/西司他汀钠混悬液在5mL碘化造影剂中栓塞显示高血管染色的分支(造影剂红)。术后1天、1周、1个月、3个月、6个月、9个月、12个月分别采用视觉模拟评分(VAS)对疼痛进行评分。结果:11/12例患者可超选择性栓塞高血管染色区PTA分支(技术成功率91.7%,平均栓塞动脉数1.5±0.7条,平均栓塞剂用量1.1±0.5 mL)。术后第1天VAS评分显著降低(2.27±1.19 vs. 7.36±0.92)p结论:超选择性TAE应用亚胺培南/西司他汀钠缓解PF难治性疼痛是可行、安全、有效的,不良事件风险低。
{"title":"Superselective Transarterial Embolization Using Imipenem/Cilastatin Sodium for Plantar Fasciitis Refractory to Conservative Management","authors":"Neeraj Kumar DM , Niraj Nirmal Pandey DM , Sanjeev Kumar MD , Aprateem Mukherjee DM , Vikrant Manhas MS , Priya Jagia MD","doi":"10.1016/j.jvir.2026.108556","DOIUrl":"10.1016/j.jvir.2026.108556","url":null,"abstract":"<div><h3>Purpose</h3><div>To assess the feasibility, safety, and effectiveness of superselective transarterial embolization (TAE) using imipenem/cilastatin sodium for plantar fasciitis (PF) refractory to conservative management.</div></div><div><h3>Materials and Methods</h3><div>This retrospective study included 12 patients (50% men; mean age, 36 years [SD ± 9.07]) with PF (pain on palpation along the proximal plantar fascia and thickened plantar fascia [>4 mm] on magnetic resonance [MR] imaging) refractory to conservative management for ≥3 months. Superselective cannulation of branches from the posterior tibial artery (PTA), supplying the point of maximal pain at the plantar fascia origin, was performed, and branches showing hypervascular staining (contrast blush) were embolized using a suspension of 500 mg of imipenem/cilastatin sodium in 5 mL of iodinated contrast agent. Visual analog scale (VAS) was used to assess pain at baseline, 1 day, 1 week, 1 month, 3 months, 6 months, 9 months, and 12 months after procedure.</div></div><div><h3>Results</h3><div>PTA branches supplying area of hypervascular staining could be superselectively embolized in 11 of 12 patients (technical success, 91.7%; mean number of arteries embolized, 1.5 [SD ± 0.7]; mean amount of embolizing agent used, 1.1 mL [SD ± 0.5]). A significant decrease in VAS score was noted on day 1 after procedure (2.27 [SD ±1.19] vs 7.36 [SD ± 0.92]; <em>P</em> < .0001), which persisted through 12 months of follow-up. Clinical success, defined as ≥50% reduction in VAS score at 6 months, was achieved in 8 of 11 (72.73%) patients who underwent embolization and was sustained through 12 months of follow-up.</div></div><div><h3>Conclusions</h3><div>Superselective TAE using imipenem/cilastatin sodium is feasible, safe, and effective in alleviating pain associated with PF refractory to conservative management, with a low risk of adverse events.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 4","pages":"Article 108556"},"PeriodicalIF":2.6,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146088064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To compare three left adrenal vein sampling sites-the left adrenal central vein (LCV), the peripheral common trunk (P-CMT), which is near the confluence of the inferior phrenic vein and LCV, and the middle common trunk (M-CMT)-and attempt to identify the reliable site for left adrenal vein sampling(AVS).
Materials and methods: Consecutive primary aldosteronism(PA) patients who underwent AVS at a general hospital (September 2019-October 2023) were enrolled. Procedure details and clinical data were collected to analyze the success rates of blood sampling (selectivity index[SI] ≥2) , aldosterone-to-cortisol (A/C) ratios, and bilateral suppression characteristics.
Results: Among the 155 enrolled patients (90 males), both LCV and P-CMT had higher cortisol levels, SI, and success rates than M-CMT (p<0.05). No meaningful differences were observed between LCV and P-CMT. In the 126 patients with successful sampling, LCV had higher cortisol levels than P-CMT, but no significant difference were observed in plasma aldosterone concentration (PAC), A/C ratios, and lateralization index (LI) . LI cutoffs (≥2 or ≥4) showed no difference in dominant side determination. Pearson analysis confirmed strong correlations in plasma cortisol, PAC, and LI between LCV and P-CMT. Apparent bilateral adrenal suppression (ABAS) rates did not differ significantly between P-CMT and LCV.
Conclusions: The peripheral common trunk is a valid and practical alternative to the left central adrenal vein for successful left adrenal vein sampling.
{"title":"Equivalence of the peripheral common trunk and adrenal central vein in left adrenal vein sampling.","authors":"Yuhai Zhang, Meihui Huang, Jingwen Yu, Weiping Wei, Tuanyu Fang","doi":"10.1016/j.jvir.2026.108557","DOIUrl":"https://doi.org/10.1016/j.jvir.2026.108557","url":null,"abstract":"<p><strong>Purpose: </strong>To compare three left adrenal vein sampling sites-the left adrenal central vein (LCV), the peripheral common trunk (P-CMT), which is near the confluence of the inferior phrenic vein and LCV, and the middle common trunk (M-CMT)-and attempt to identify the reliable site for left adrenal vein sampling(AVS).</p><p><strong>Materials and methods: </strong>Consecutive primary aldosteronism(PA) patients who underwent AVS at a general hospital (September 2019-October 2023) were enrolled. Procedure details and clinical data were collected to analyze the success rates of blood sampling (selectivity index[SI] ≥2) , aldosterone-to-cortisol (A/C) ratios, and bilateral suppression characteristics.</p><p><strong>Results: </strong>Among the 155 enrolled patients (90 males), both LCV and P-CMT had higher cortisol levels, SI, and success rates than M-CMT (p<0.05). No meaningful differences were observed between LCV and P-CMT. In the 126 patients with successful sampling, LCV had higher cortisol levels than P-CMT, but no significant difference were observed in plasma aldosterone concentration (PAC), A/C ratios, and lateralization index (LI) . LI cutoffs (≥2 or ≥4) showed no difference in dominant side determination. Pearson analysis confirmed strong correlations in plasma cortisol, PAC, and LI between LCV and P-CMT. Apparent bilateral adrenal suppression (ABAS) rates did not differ significantly between P-CMT and LCV.</p><p><strong>Conclusions: </strong>The peripheral common trunk is a valid and practical alternative to the left central adrenal vein for successful left adrenal vein sampling.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":"108557"},"PeriodicalIF":2.6,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146088050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}